ルテインサプリメントの世界市場-2024-2031年

概要

ルテインサプリメントの世界市場は、2023年に1億6,520万米ドルに達し、2031年には2億6,730万米ドルに達すると予測され、予測期間2024-2031年のCAGRは6.2%で成長する見込みです。

ルテインサプリメントの市場は、近年世界的に大きく成長しているが、その主な理由は、予防ヘルスケアと目の健康の価値に対する消費者の意識の高まりによるものです。緑黄色野菜に多く含まれるルテインはカロテノイドの一種で、抗酸化作用や目の健康、特に白内障や加齢黄斑変性症（AMD）の予防に役立つことで知られています。

ルテインサプリメントの市場は、世界の高齢化人口の増加や、長時間の画面使用によるデジタル眼精疲労への懸念の高まりとともに拡大しています。さらに、製剤の技術開発の結果、新たな送達方法や配合製品が生み出され、これが市場拡大にさらに拍車をかけています。

天然ルテインサプリメントが市場シェアの半分以上を占めています。同様に、北米がルテインサプリメント市場を独占しており、1/3以上の最大市場シェアを獲得しています。北米では、薬局、健康食品店、スーパーマーケット、オンライン小売店など、ルテインサプリメントを購入するための多様な小売チャネルが提供されています。

ダイナミクス

世界の高齢化

世界人口の高齢化に伴い、加齢に伴う眼疾患の発生率が増加しています。例えば、AMDは高齢者における不可逆的な視覚喪失の世界の主原因の一つです。AMDのリスクは加齢とともに上昇するため、ルテインサプリメントのような予防的治療の必要性が高まっています。国連によると、65歳以上の高齢者の割合は、それ以下の高齢者よりも速いペースで増加しています。

2022年には、65歳以上の人口は世界で7億7,100万人となり、世界人口のほぼ10％を占める。この層は2050年には16％に達し、最終的には2100年には24％になると予想されています。この人口ベースの調査では、人口高齢化の影響が1億8,337万件の視力喪失に関連していることが示されました。近見視力低下、屈折障害、白内障は人口の高齢化とともに最も増加しました。

高齢になるにつれて、加齢に伴う視力低下や目の健康に関連する問題に対する意識が高まっています。優れた視力を維持し、眼障害の発症を食い止めるために、積極的な対策が取られるようになってきています。目の健康のためのルテインサプリメントの利点がより広く認識されるようになると、高齢者はより多くの割合でそれらを使用しています。

製剤における技術の進歩

脂質ベースの製剤、ナノエマルジョン、マイクロカプセル化技術などの革新的な送達方法は、技術の飛躍的進歩によって可能になりました。ルテインの溶解性と安定性を高めることで、これらの最先端技術はそのバイオアベイラビリティを最大化し、栄養素の体内吸収を高める。このため、消費者は低用量のルテインサプリメントからより多くの恩恵を受ける可能性があり、市場の需要が高まると思われます。

2024年2月、OmniActive Health TechnologiesがLutemax Kidsとして販売したルテインとゼアキサンチンの異性体の低用量製剤は、5歳から12歳までの60人の子供のコホートにおいて、認知能力の向上と目の健康の測定に関連していました。ルテインは熱、光、酸素によって容易に分解されるため、製剤中の有効性に影響が出る可能性があります。

リポソームやナノ粒子のカプセル化、マイクロカプセル化といった最先端の製剤技術は、ルテインを酸化や劣化から守り、保存期間を延ばし、製品の効能を維持するのに役立ちます。その結果、顧客の信頼と忠誠心が高まり、製品の保存期間中、一定のルテイン濃度を持つ高品質の製品が保証されます。

規制上の制約とコンプライアンスの課題

規制上の制約とコンプライアンスの課題は、世界のルテインサプリメント市場に大きな抑制要因となっています。他の栄養補助食品と同様に、ルテインサプリメントは、米国の食品医薬品局（FDA）、欧州の欧州食品安全機関（EFSA）、および世界中の同様の機関のような規制当局によって課される厳しい規制と品質基準の対象となります。

ルテインサプリメントメーカーが直面する主な課題の一つは、栄養補助食品を管理する複雑な規制状況を乗り切ることです。規制は国や地域によって異なる可能性があり、メーカーが製品を世界に市場に投入するためには、複数の規制の枠組みを乗り越える必要があります。表示要件、成分規格、健康強調表示、安全性評価への準拠は、製品開発プロセスに複雑さをもたらし、規制準拠に関連する時間とコストを増加させる可能性があります。

目次

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 世界の高齢化
    • 製剤技術の進歩
  • 抑制要因
    • 規制上の制約とコンプライアンスの課題
  • 機会
  • 影響分析

第5章 産業分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• 価格分析
• 規制分析
• ロシア・ウクライナ戦争の影響分析
• DMIの見解

第6章 COVID-19分析

第7章 成分別

• ゼアキサンチン
• ビタミンとミネラル
• オメガ3脂肪酸
• 酸化防止剤
• その他

第8章 形態別

• 粉末
• 液体
• グミ
• 錠剤
• その他

第9章 包装別

• ボトル
• 小袋
• ブリスターパック
• その他

第10章 用途別

• 目の健康と視力サポート
• 抗酸化サプリメント
• スポーツ栄養
• 皮膚の健康
• 脳の健康と認知機能
• その他

第11章 流通チャネル別

• スーパーマーケット/ハイパーマーケット
• オンライン小売
• 薬局・ドラッグストア
• その他

第12章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東およびアフリカ

第13章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第14章 企業プロファイル

• Kemin Industries
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• OmniActive Health Technologies
• BASF SE
• DSM
• PIVEG, Inc.
• Allied Biotech Corporation
• Vitae Naturals
• Fenchem Inc.
• Chr. Hansen Holding A/S
• Nature's Way Products, LLC.

第15章 付録

Overview

Global Lutein Supplements Market reached US$ 165.2 million in 2023 and is expected to reach US$ 267.3 million by 2031, growing with a CAGR of 6.2% during the forecast period 2024-2031.

The market for lutein supplements has grown significantly globally in recent years, mostly due to rising consumer awareness of the value of preventative healthcare and eye health. Naturally abundant in leafy green vegetables, lutein is a carotenoid that is well-known for its antioxidant qualities and its support of eye health, especially in preventing cataracts and age-related macular degeneration (AMD).

The market for lutein supplements has increased as the world's aging population rises and worries about digital eye strain from prolonged screen usage increase. Furthermore, new delivery methods and combination products have been created as a result of technological developments in formulations, which has further fueled market expansion.

The natural lutein supplements account for over half of the market share. Similarly, North America dominates the lutein supplements market, capturing the largest market share of over 1/3rd. North America offers a diverse range of retail channels for purchasing lutein supplements, including pharmacies, health food stores, supermarkets, and online retailers.

Dynamics

Aging Population across the Globe

The incidence of age-related eye disorders has increased in tandem with the aging of the world's population. For instance, AMD is one of the main global causes of irreversible visual loss in the elderly. The risk of AMD rises with age, which raises the need for preventive treatments like lutein supplements. According to the United Nations, the percentage of people aged 65 and above is growing at a faster rate than those below that age.

In 2022, 771 million people aged 65 and above were living globally, accounting for almost 10% of the world's population. This segment is expected to reach 16% in 2050, and eventually 24% by 2100. This population-based study showed that the impact of population aging was associated with 183.37 million vision loss cases. Near vision loss, refraction disorders, and cataract increased most with population aging.

People grow increasingly aware of the problems linked with age-related vision loss and their eye health as they get older. Proactive steps are being taken more often to preserve excellent eyesight and stop the development of eye disorders. As the benefits of lutein supplements for eye health become more widely acknowledged, older persons are using them at larger rates.

Technological Advancements in Formulations

Innovative delivery methods, including lipid-based formulations, nanoemulsions, and microencapsulation techniques, have been made possible by technological breakthroughs. By increasing lutein's solubility and stability, these cutting-edge techniques maximize its bioavailability and boost the nutrient's absorption throughout the body. Because of this, consumers might benefit more from lutein supplements at lower dosages, which will increase demand in the market.

In February 2024, a low-dose formulation of lutein and zeaxanthin isomers marketed as Lutemax Kids by OmniActive Health Technologies was associated with improvements in cognitive performance and measures of eye health in a cohort of 60 children between the ages of five and 12. Considering lutein is easily degraded by heat, light, and oxygen, its effectiveness in formulations may be impacted.

Cutting-edge formulation techniques, such as liposome or nanoparticle encapsulation and microencapsulation, help shield lutein from oxidation and degradation, increasing its shelf life and preserving product potency. As a result, customers' trust and loyalty are increased and they are guaranteed to obtain a high-quality product with constant lutein levels throughout the product's shelf life.

Regulatory Constraints and Compliance Challenges

Regulatory constraints and compliance challenges pose a significant restraint to the global lutein supplements market. As with any dietary supplement, lutein supplements are subject to stringent regulations and quality standards imposed by regulatory authorities such as the Food and Drug Administration (FDA) in the United States, the European Food Safety Authority (EFSA) in Europe, and similar agencies worldwide.

One of the main challenges faced by lutein supplement manufacturers is navigating the complex regulatory landscape governing dietary supplements. Regulations may vary between countries and regions, requiring manufacturers to navigate multiple regulatory frameworks to bring their products to market globally. Compliance with labeling requirements, ingredient specifications, health claims, and safety assessments adds complexity to the product development process and may increase time and costs associated with regulatory compliance.

Segment Analysis

The global lutein supplements market is segmented based on ingredient, form, packaging, application, distribution channel and region.

Surge in the Demand for Vitamins and Minerals Ingredients

It has been demonstrated that lutein and other vitamins and minerals, including zinc, copper, and the C and E vitamins, combine to promote eye health. In order to combat free radicals and lessen oxidative stress in the eyes, these nutrients are essential components of antioxidant defense systems. Lutein supplements provide all-encompassing support for ocular wellbeing by mixing lutein with key vitamins and minerals, addressing several facets of eye health at once.

In the eye, lutein functions as a strong antioxidant in conjunction with vitamins C and E, guarding against oxidative damage brought on by exposure to blue light and ultraviolet (UV) radiation. Zinc and copper are necessary cofactors for antioxidant enzymes, and vitamin C aids in the regeneration of vitamin E, boosting its antioxidant action.

In February 2022, a wide range of cutting-edge supplements called TrueYou has been introduced by the Vitamin Shoppe, an omni-channel specialty retailer of nutritional items, to meet the distinct and changing needs of women at every stage of their lives. TrueYou, which is made with lutein blended with high-quality vitamin ingredients, mainly by B12 and supported by science, was developed to encourage self-care and balanced health while enabling each woman to express her unique potential.

Geographical Penetration

Health and Wellness Trends in North America

North Americans have a strong emphasis on health and wellness, and they are becoming more and more aware of the need of natural remedies and preventative healthcare in preserving general wellbeing. These trends are supported by lutein supplements, which are marketed as safe, natural dietary supplements that promote eye health. As part of their daily routine, consumers are actively looking for lutein supplements to promote good vision and prevent age-related eye disorders.

Over 8.18 million people in the U.S reported having a vision disability in 2022, according to the Census Bureau's American Community Survey. They are either blind or have difficulty seeing even when wearing glasses. In the U.S alone in 2023, about 12 million people age 40 and above suffer from vision impairment, with about a million suffering from blindness.

In North America, there is an increasing emphasis on preventative healthcare, which has raised awareness of the significance of eye health and the role that nutrition plays in preserving ideal vision. For people who are at risk of developing age-related eye disorders or who are currently experiencing them, medical practitioners often advise taking lutein supplements as a preventive strategy. The use of lutein supplements by consumers has increased as a result of this recommendation.

COVID-19 Impact Analysis

Global supply systems were thrown off balance by the epidemic, which resulted in shortages of raw materials and delays in the production and delivery of goods. These issues were made worse by limitations on international trade and transportation, which had an impact on the market's supply of lutein supplements.

Throughout the epidemic, people's concerns shifted to their health and well-being, which led to an increase in demand for nutritional supplements, especially lutein supplements. The need for items that might boost their general health and immune system caused lutein supplement sales to rise.

Changes in consumer buying patterns were brought about by the pandemic's economic effects, which included job losses and financial instability. Some consumers prioritized buying health-related products, such as lutein supplements, to maintain their health and energy, while others reduced their discretionary spending.

Lockdowns and social distancing tactics compelled numerous physical retailers to either temporarily lock their doors or operate at reduced capacity. As a result, more people started buying lutein supplements online through internet retail channels. During the epidemic, e-commerce platforms became crucial for connecting with customers and sustaining revenues.

Russia-Ukraine War Impact Analysis

The crisis involving Russia and Ukraine affected supply chains and trade routes, which in turn affected the availability of raw materials needed to produce lutein supplements. Manufacturers and suppliers are worried about the stability of the supply chain and the possibility of trade interruptions. Global markets are unstable as a result of the geopolitical tensions between Russia and Ukraine, which has an impact on consumer and investor confidence.

The demand for lutein supplements may fluctuate as a result of this uncertainty as consumers become more frugal with their money. International commerce flows could be disrupted by the conflict between Russia and Ukraine, which would raise shipping and logistical costs and cause delays. Longer lead times and increased transportation costs may have an impact on lutein supplement availability and pricing in various geographic areas, which could alter market dynamics.

Particularly in Eastern Europe and the surrounding nations, the conflict may have special geographical effects on the market for lutein supplements. The demand for lutein supplements may be impacted by the political and economic unrest and diminished consumer confidence in these areas.

By Ingredient

• Zeaxanthin
• Vitamins and Minerals
• Omega-3 Fatty Acids
• Antioxidants
• Others

By Form

• Powder
• Liquid
• Gummies
• Tablets
• Others

By Packaging

• Bottles
• Sachets
• Blister Packs
• Others

By Application

• Eye Health and Vision Support
• Antioxidant Supplements
• Sports Nutrition
• Skin Health
• Brain Health and Cognitive Function
• Others

By Distribution Channel

• Supermarkets/Hypermarkets
• Online Retail
• Pharmacies and Drug Stores
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Rest of Europe
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
• Middle East and Africa

Key Developments

• In February 2024, EyePromise, a company that specializes in supplementing eye health, announced the release of BrainPromise, a blend of vital minerals, vitamins and the carotenoids lutein and zeaxanthin. The supplement includes specific ingredients such as vitamins A, C, D3, E, B6, B12, folic acid, zinc, omega-3s, CoQ10, alpha lipoic acid, selenium, manganese, bilberry, zeaxanthin, lutein, mixed tocotrienols/tocopherols, and a proprietary blend.
• In February 2023, Herbalife Nutrition India launched a new supplement to target the eye health market. Lutein and zeaxanthin are combined in the scientifically formulated supplement Ocular Defense.
• In May 2021, PharmaLinea launched a range of consumer-friendly vitamins for eye health prevention. The decision was made at a time when screen usage has increased due to the epidemic and concerns about eye health are on the rise.

Competitive Landscape

The major global players in the market include Kemin Industries, BASF SE, DSM, PIVEG, Inc., Allied Biotech Corporation, Vitae Naturals, Fenchem Inc., Chr. Hansen Holding A/S and Nature's Way Products, LLC.

Why Purchase the Report?

• To visualize the global lutein supplements market segmentation based on ingredient, form, packaging, application, distribution channel, and region as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of Lutein Supplements market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as excel consisting of key products of all the major players.

The global lutein supplements market report would provide approximately 78 tables, 80 figures and 229 Pages.

Target Audience 2024

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

Table of Contents

1.Methodology and Scope

• 1.1.Research Methodology
• 1.2.Research Objective and Scope of the Report

2.Definition and Overview

3.Executive Summary

• 3.1.Snippet By Ingredient
• 3.2.Snippet by Form
• 3.3.Snippet by Packaging
• 3.4.Snippet by Application
• 3.5.Snippet by Distribution Channel
• 3.6.Snippet by Region

4.Dynamics

• 4.1.Impacting Factors
  • 4.1.1.Drivers
    • 4.1.1.1.Aging Population across the Globe
    • 4.1.1.2.Technological Advancements in Formulations
  • 4.1.2.Restraints
    • 4.1.2.1.Regulatory Constraints and Compliance Challenges
  • 4.1.3.Opportunity
  • 4.1.4.Impact Analysis

5.Industry Analysis

• 5.1.Porter's Five Force Analysis
• 5.2.Supply Chain Analysis
• 5.3.Pricing Analysis
• 5.4.Regulatory Analysis
• 5.5.Russia-Ukraine War Impact Analysis
• 5.6.DMI Opinion

6.COVID-19 Analysis

• 6.1.Analysis of COVID-19
  • 6.1.1.Scenario Before COVID
  • 6.1.2.Scenario During COVID
  • 6.1.3.Scenario Post COVID
• 6.2.Pricing Dynamics Amid COVID-19
• 6.3.Demand-Supply Spectrum
• 6.4.Government Initiatives Related to the Market During Pandemic
• 6.5.Manufacturers Strategic Initiatives
• 6.6.Conclusion

7.By Ingredient

• 7.1.Introduction
  • 7.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  • 7.1.2.Market Attractiveness Index, By Ingredient
• 7.2.Zeaxanthin*
  • 7.2.1.Introduction
  • 7.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 7.3.Vitamins and Minerals
• 7.4.Omega-3 Fatty Acids
• 7.5.Antioxidants
• 7.6.Others

8.By Form

• 8.1.Introduction
  • 8.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 8.1.2.Market Attractiveness Index, By Form
• 8.2.Powder*
  • 8.2.1.Introduction
  • 8.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3.Liquid
• 8.4.Gummies
• 8.5.Tablets
• 8.6.Others

9.By Packaging

• 9.1.Introduction
  • 9.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
  • 9.1.2.Market Attractiveness Index, By Packaging
• 9.2.Bottles*
  • 9.2.1.Introduction
  • 9.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3.Sachets
• 9.4.Blister Packs
• 9.5.Others

10.By Application

• 10.1.Introduction
  • 10.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 10.1.2.Market Attractiveness Index, By Application
• 10.2.Eye Health and Vision Support*
  • 10.2.1.Introduction
  • 10.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3.Antioxidant Supplements
• 10.4.Sports Nutrition
• 10.5.Skin Health
• 10.6.Brain Health and Cognitive Function
• 10.7.Others

11.By Distribution Channel

• 11.1.Introduction
  • 11.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.1.2.Market Attractiveness Index, By Distribution Channel
• 11.2.Supermarkets/Hypermarkets*
  • 11.2.1.Introduction
  • 11.2.2.Market Size Analysis and Y-o-Y Growth Analysis (%)
• 11.3.Online Retail
• 11.4.Pharmacies and Drug Stores
• 11.5.Others

12.By Region

• 12.1.Introduction
  • 12.1.1.Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 12.1.2.Market Attractiveness Index, By Region
• 12.2.North America
  • 12.2.1.Introduction
  • 12.2.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient

• 12.2.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
• 12.2.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
• 12.2.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 12.2.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
• 12.2.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 12.2.7.1.U.S.
  • 12.2.7.2.Canada
  • 12.2.7.3.Mexico
• 12.3.Europe
  • 12.3.1.Introduction
  • 12.3.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient

• 12.3.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
• 12.3.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
• 12.3.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 12.3.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
• 12.3.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 12.3.7.1.Germany
  • 12.3.7.2.UK
  • 12.3.7.3.France
  • 12.3.7.4.Italy
  • 12.3.7.5.Spain
  • 12.3.7.6.Rest of Europe
• 12.4.South America
  • 12.4.1.Introduction
  • 12.4.2.Key Region-Specific Dynamics

Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient

• 12.4.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
• 12.4.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
• 12.4.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
• 12.4.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
• 12.4.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  • 12.4.7.1.Brazil
  • 12.4.7.2.Argentina
  • 12.4.7.3.Rest of South America
• 12.5.Asia-Pacific
  • 12.5.1.Introduction
  • 12.5.2.Key Region-Specific Dynamics
  • 12.5.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  • 12.5.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.5.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
  • 12.5.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.5.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 12.5.8.Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 12.5.8.1.China
    • 12.5.8.2.India
    • 12.5.8.3.Japan
    • 12.5.8.4.Australia
    • 12.5.8.5.Rest of Asia-Pacific
• 12.6.Middle East and Africa
  • 12.6.1.Introduction
  • 12.6.2.Key Region-Specific Dynamics
  • 12.6.3.Market Size Analysis and Y-o-Y Growth Analysis (%), By Ingredient
  • 12.6.4.Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
  • 12.6.5.Market Size Analysis and Y-o-Y Growth Analysis (%), By Packaging
  • 12.6.6.Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 12.6.7.Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

13.Competitive Landscape

• 13.1.Competitive Scenario
• 13.2.Market Positioning/Share Analysis
• 13.3.Mergers and Acquisitions Analysis

14.Company Profiles

• 14.1.Kemin Industries*
  • 14.1.1.Company Overview
  • 14.1.2.Product Portfolio and Description
  • 14.1.3.Financial Overview
  • 14.1.4.Key Developments
• 14.2.OmniActive Health Technologies
• 14.3.BASF SE
• 14.4.DSM
• 14.5.PIVEG, Inc.
• 14.6.Allied Biotech Corporation
• 14.7.Vitae Naturals
• 14.8.Fenchem Inc.
• 14.9.Chr. Hansen Holding A/S
• 14.10.Nature's Way Products, LLC.

LIST NOT EXHAUSTIVE

15.Appendix

• 15.1.About Us and Services
• 15.2.Contact Us